Location : Barcelona - Spain (3 days working from the office and 2 days working from home)

At Alexion, AstraZeneca Rare Disease , this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living withrare neurological diseases . You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on the NMOSD indication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition within Neurology .

Whatyou’llwilldo:

Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZenecais able toensure that appropriate access is provided to our transformative therapies.

Alexion, AstraZeneca Rare Disease’s Global Value Access and Pricing (GVAP ) team is seeking a qualified Director to join a dynamic and growing team, with responsibility for Neurology indications, including near-term new product launches and label expansions.

As a key member of theGVAP team, you will help shape and execute global value, access, and pricing strategies across theNeurology portfolio in selected key EU markets , withparticular strategicfocus on theNMOSD indication and its lifecycle management





This is a strategic role that leverages your understanding and application of integral healthcare and health technology assessment (HTA ) systems, competitive insights, and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications.

The ideal candidate for this role will have deep expertise in global payer, HTA , and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success within rare diseases and Neurology .

You will be responsible for:

Value

Lead and drive cross-functional development of a clear, differentiated value proposition for NMOSD , while influencing without authority and navigating complex organizational systems.

Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence (RWE ) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries.

Provide support to the GMMA Commercial team to advance NMOSD lifecycle management (LCM) through governance milestones focused on market access potential, evidence, and target product profile (TPP) requirements.

Access





Leaddevelopment ofglobal market access and pricing strategies-activitiesandsupport implementationin close partnership with country access representativesofassigned countries

Lead the assessment of pricing and reimbursement (P&R; ) risks and opportunities, and the implementation of corresponding mitigation actions specific to Neurology .

Create and roll out strategic value, access, and pricing communication tools and materials for NMOSD to support local P&R; submissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework.

Lead the update of the global reimbursement dossier for NMOSD and the overall cross-functional market access readiness plans for Neurology , in close collaboration with key countries and support functions (HEOR, Medical, and Commercial ).

Represent the GVAP perspective and strategy across various cross-functional teams, including the Global Value Sub-Team and Global Launch Team , and provide updates and guidance to local teams as needed.

Own the monthlyNeurologypayer working group to share the latest evidence and drive best practice sharing across countries.

Understand and incorporate thepatientperspective on thedisease, andrecommend strategies that support thepatientvoice in key payer negotiations.

Pricing

Support the development oftheNeurology pricing strategy.

Conduct payer and value assessments to identify key market-specific P&R; drivers and barriers, develop differentiated value propositions, and inform evidence generation plans, regulatory

📌 Global Pricing (Barcelona)
🏢 Alexion Pharmaceuticals
📍 Barcelona